LeukemiaLeukemia, Myeloid, AcuteHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, MyeloidAcute DiseaseGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationRemission InductionBone Marrow TransplantationTreatment OutcomeTransplantation ChimeraStem CellsGraft vs Leukemia EffectRecurrenceBusulfanVidarabineMyelodysplastic SyndromesCytarabineTissue DonorsMyeloablative AgonistsLeukemia, Lymphocytic, Chronic, B-CellGraft vs Tumor EffectNeoplasm, ResidualHematopoietic Stem CellsDisease-Free SurvivalHistocompatibility Testingfms-Like Tyrosine Kinase 3Fusion Proteins, bcr-ablSurvival AnalysisRetrospective StudiesGraft SurvivalSurvival RateLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyBenzamidesAntineoplastic AgentsPrognosisLeukemia, Biphenotypic, AcuteGene Expression Regulation, LeukemicImmunosuppressive AgentsWhole-Body IrradiationBlast CrisisMultiple MyelomaSalvage TherapyCord Blood Stem Cell TransplantationCytogenetic AnalysisBone MarrowPyrimidinesLeukemia, LymphoidSiblingsPiperazinesLeukemia, Monocytic, AcuteMinor Histocompatibility AntigensCytomegalovirus InfectionsTime FactorsLymphocyte DepletionAntilymphocyte SerumHistocompatibilityAntigens, CD34Leukemia, Myeloid, Accelerated PhaseLiver TransplantationCyclophosphamideLeukemia, Myelomonocytic, AcuteVirus ActivationT-LymphocytesMelphalanFollow-Up StudiesDaunorubicinHepatic Veno-Occlusive DiseaseIdarubicinLeukemia, ExperimentalChimerismKaryotypingImmunophenotypingHematopoietic Stem Cell MobilizationFlow CytometryPrimary MyelofibrosisMyeloid-Lymphoid Leukemia ProteinHLA AntigensAnemia, AplasticCell DifferentiationMesenchymal Stem Cell TransplantationCytomegalovirusGranulocyte Colony-Stimulating FactorHematologic DiseasesBone Marrow CellsEtoposidePhiladelphia ChromosomeHL-60 CellsCell TransplantationCore Binding Factor Alpha 2 SubunitAntibodies, Neoplasm